ArticleMolecular biology reports2026
Improvement of soluble expression of anti-PD-1/CTLA-4 diabody in the cytoplasm of Escherichia coli.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Escherichia coli is one of the most efficient and widely used expression systems for the production of biopharmaceuticals. Despite all its many advantages, E. coli cannot efficiently produce complex, high molecular weight proteins produce complexmonoclonal antibodies and diabodies. In this study, the cytoplasmic soluble expression of a previously designed anti-PD-1/CTLA-4 single chain diabody (scDb) was evaluated at different incubation temperatures (15, 23, 30, and 37 °C) and IPTG concentrations (0.1, 0.5, and 1 mM) in E. coli BL21(DE3), Origami B(DE3), and SHuffle T7 strains. The effect of co-expression of the DnaK, DnaJ and GrpE chaperone on soluble protein expression was also investigated in E. coli BL21(DE3). The results showed that E. coli SHuffle T7 produced the highest expression of soluble protein. Lower incubation temperature increased the yield of soluble protein in all strains, whereas IPTG concentration had a negligible effect. Co-expression of chaperones in the E. coli BL21(DE3) also improved protein solubility compared with expression of the scDb alone. These findings suggest that E. coli SHuffle T7 is a promising host for the production of recombinant proteins production. In addition, chaperone co-expression and reduced incubation temperature can be considered effective strategies for higher soluble protein production.
Indexed as
Identifiers
42525183What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.